Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-01-10
2006-01-10
O'Sullivan, Peter (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S562000, C514S563000, C514S564000, C514S566000, C562S439000, C562S431000, C549S439000
Reexamination Certificate
active
06984661
ABSTRACT:
The present invention is directed to compounds of the structural formula (I), and pharmaceutically acceptable salts, solvates and hydrates thereof: Formula I (a) R1, R2 and R6 are each independently selected from the group consisting of hydrogen, C1-C8alkyl substituted C1-C8alkyl, aryl-C0-4-alkyl, substituted aryl-C0-4-alkyl, heteroaryl-C0-4-alkyl, substituted heteroaryl-C0-4-alkyl, C3-C6cycloalkylaryl-C0-2-alkyl, and substituted C3-C6cycloalkylaryl-C0-2-alkyl; (b) X is an optionally substituted C1-C5alkylene linker wherein one carbon atom of the linker may be replaced with O, NH or S; (c) Y is C, O, S, NH or a single bond; and (d) E is selected from the group consisting of hydrogen, C(R3)(R4)A, A, (CH2)nCOOR19 and substituted (CH2)nCOOR19.
REFERENCES:
patent: 4387106 (1983-06-01), De Vries et al.
patent: 4465509 (1984-08-01), Takematsu et al.
patent: 6706744 (2004-03-01), Madsen et al.
patent: 14 57 876 (1969-05-01), None
patent: WO 01 12187 (2001-02-01), None
patent: WO 01 60807 (2001-08-01), None
CA 'Online!: Chemical Abstracts Service, Columbus, OH, US; Sato, et al.,: “Urea Group-Containing Carboxylic Acids and Hypoglycemic and/or Hypolipidemic Agents Containing Them”; retrieved from STN database accession No. 137:87463, XP0022411118, abstract & JP 2002 201171 A (Toa Eiyo, Ltd., Japan) Jul. 15, 2002.
WPI/Derwent Online; XP002241120; Database Accession No. an 1999-229131 '19!; Abstract & WO 00 12534 A (Univ. Northeastern Ohio) Mar. 9, 2000, abstract; pp. 23-29, 34, 36, 37.
Raju, B., et al.: “Solution-phase Combinatorial synthesis of Ureas Using Nitrophenylcarbamates”; BioOganic & Medicinal Chemistry Letters, Oxford, GB; vol. 8, No. 21, Nov. 3, 1998, pp. 3043-3048, XP004141872; ISSN: 0960-894X (scheme 1, compound type 7; table 1).
Nefzi, A., et al.: “An Efficient Two-Step Synthesis of Mono-, Di- and Triureas from Resin-bound Amides”; Tetrahedron Letters, Elsevier Science Publishers, Amsterdam, NL; vol. 40, No. 29, Jul. 15, 2000, pp. 5441-5446, XP0042094891, ISSN: 0040-4039 (compounds type 3, table 1).
Ishii, et al.: “Highly Selective Aldose Reductase Inhibitors 1,3-(Arylalkyl)-2, 4, 5-Trioxoimidazolidine-I-Asetic Acids”;Journal of Medicinal Chemistry, American Chemical Society, Washington, US; vol. 39, No. 9, (1996), pp. 1924-1927, XP002064894, ISSN: 0022-2623.
Tanka, et al.: “Inhibitors of Acyl-CoA;Cholesterol O-Acyltransferase(ACAT), Part I: Identification and Structure-Activity Relationships of a Novel Series of Substituted N-Alkyl-N-Biphenylmethyl-N'-Arylcureas”BioOrganic and Medicinal Chemistry, vol. 6, 1998, pp. 15-30, XP002241118(the whole document).
Crossfire Beilstein 'Online!: Beilstein Institut zur Förderung der Chemischen Wissenschaften, Frankfurt am Main, De; retrived from Beilstein, accession No. brn 2890655, XP002241121; Abstract & Vowinkel; Gleichenhagen: Tetrahedron Lett., 1974, pp. 143-146.
Crossfire Beistein 'Online!: Beilstein Institut zur Förderung der Chemischen Wissenschaften, Frankfurt am Main, DE; retrieved from Beilstein, accession No. brn 3271886, XP002241122; Abstract & Lohman: Chem. Ber., vol. 24m 1891, p. 2635.
Crossfire Beilstein 'Online!: Beilstein Institut zur Förderung der Chemischen Weissenschaften, Frankfurt am Main, DE; retrived from Beilstein, accession No. brn 3530969, XP002241123, abstract & Gabriel; Chem. Ber., vol. 47, 1914, p. 3030.
Crossfire Beilstein 'Online!: Beilstein Institut zur Förderung der Chemischen Wissenschaften, Frankfurt am Main, DE; retrieved from Beilstein, accession No. brn 2451140; XP002241124; abstract & Spinzl, M., et al.: Tetrahedron Lett., vol. 5, 1969, pp. 289-292.
Crossfire Beilstein 'Online!: Beilstein Institut zur Förderung der Chemischen Wissenschaften, Frankfurt am Main, DE; retrived from Beilstein, accession No. brn 247670, XP002241125, abstract & Koelzer and Wehr: Arzneim. Forsch., vol. 9, 1959, pp. 113-116.
Crossfire Beilstein 'Online!: Beilstein Institut zur Förderung der Chemischen Wissenschaften, Frankfurt am Main, DE; retrieved from Beilstein, accession No. brn 2812220, XP002241126, abstract & Adcock; Lawson: J. Chem. Soc C., 1996, pp. 65-67.
Crossfire Beilstein 'Online!: Beilstein Institut zur Förderung der Chemischen Wissenschaften, Frankfurt am Main, DE; retrieved from Beilstein, accession No. brn 3272124; XP002241127, abstract & Schoeberl; Kawohl: Monatsh. Chem., vol. 88, 1957, pp. 478-492.
Crossfire Beilstein 'Online!: Beilstein Institut zur Förderung der Chemischen Wissenschaften, Frankfurt am Main, DE; retrieved from Beilstein, accession No. brn 3271854, XP002241128, abstract & Goldenring: Chem. Ber., No. 23, 1890, p. 1173.
Crossfire Beilstein 'Online!: Beilstein Institut zur Förderung der Chemischen Wissenschaften, Frankfurt am Main, DE; retrieved from Beilstein, accession No. brn 2860895, XP002241129, abstract & Van Alphen: Recl. Trav. Chim. Pays-Bas, vol. 54, 1935, p. 885.
Papesch, et al: “Synthesis of 1-mono- and 1,3-di-substituted 6-aminouracils, Diuretic Activity”; Journal of Organic Chemistry, American Chemical Society, Easton, US, XP002156529, ISSN: 0022-3263, (table I, the last entry and p. 1887, experimental).
Davies, et al.: “Intramolecular Cyclisation of 2-Phenylethyl Isocyanates”; J. Chem. Soc., Perkin Trans. 1, 1978, pp. 180-184, XP009010939 (compound 13).
Dimmock, et al.: “Ureylene Anticonvulsants and Related Compounds”: Pharmazie, vol. 55, No. 7, (2000), pp. 490-494, XP001157470 (compounds type 1 and table 1, p. 491).
Skinner, et al.: “N-substituted N'-Phenylureas”; J. Org. Chem., vol. 25, 1960, pp. 2046-2047, XP00241235 (table 1).
Henry James Robert
Li YiHong
Eli Lilly and Company
McCharri Vorndran-Jones
O'Sullivan Peter
LandOfFree
Urea linker derivatives for use as PPAR modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Urea linker derivatives for use as PPAR modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Urea linker derivatives for use as PPAR modulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3526500